Access Bio Signs Supply Contract for COVID-19 Diagnostic Kits Worth 10.9 Billion KRW
[Asia Economy Reporter Geum Bo-ryeong] Access Bio announced on the 16th that it has signed a supply contract worth 10.9 billion KRW for COVID-19 antigen test kits with Intrivo Diagnostics.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- "Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- "We're Now Earning 10 Million Won a Month"... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- Experts Are Already Watching Closely..."Target Stock Price 970,000 Won" Now Only the Uptrend Remains [Weekend Money]
The contract amount corresponds to 25.33% of the consolidated sales as of the end of last year. The contract end date is February 16 of next year.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
